Intensive LDL-cholesterol lowering therapy and neurocognitive function-Reference-Cited by-同舟云学术

Intensive LDL-cholesterol lowering therapy and neurocognitive function

Published:2017-02 Issue: Volume:170 Page:181-191
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Banach Maciej,Rizzo Manfredi,Nikolic Dragana,Howard George,Howard VirginiaJ.,Mikhailidis DimitriP.

Funder

AstraZeneca

MSD

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference98 articles.

1. Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: The HALCyon programme;Alfred;Age (Dordrecht, Netherlands),2014

2. Monoclonal antibodies for the treatment of hypercholesterolemia: Targeting PCSK9;Alkindi;The Canadian Journal of Cardiology,2016

3. Amgen announces positive top-line results from phase 3 GAUSS-3 trial of Repatha (evolocumab) in statin-intolerant patients with high cholesterol [press release];Amgen,2016

4. Gender-specific associations between lipids and cognitive decline in the elderly;Ancelin;European Neuropsychopharmacology,2014

5. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology;Arvanitakis;Neurology,2008

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between residual cholesterol and cognitive performance: a study based on NHANES;Frontiers in Nutrition;2024-09-11

2. Efficacy and Safety of Inclisiran, Alirocumab, Evolocumab, and Evinacumab in Lipid-Lowering: A Network Meta-Analysis;2024-04-17

3. Probiotic characteristics of Lactobacillus gasseri TF08-1: A cholesterol-lowering bacterium, isolated from human gut;Enzyme and Microbial Technology;2023-09

4. What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?;PLOS ONE;2023-05-11

5. Potential role of TREM2 in high cholesterol‑induced cell injury and metabolic dysfunction in SH‑SY5Y cells;Experimental and Therapeutic Medicine;2023-03-22